Header Logo

Connection

Cheryl Cohen to Pneumococcal Vaccines

This is a "connection" page, showing publications Cheryl Cohen has written about Pneumococcal Vaccines.
Connection Strength

3,824
  1. Estimated impact of the pneumococcal conjugate vaccine on pneumonia mortality in South Africa, 1999 through 2016: An ecological modelling study. PLoS Med. 2021 02; 18(2):e1003537.
    View in: PubMed
    Score: 0,589
  2. Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa. PLoS One. 2017; 12(7):e0179905.
    View in: PubMed
    Score: 0,458
  3. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,445
  4. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,370
  5. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study. BMJ Open. 2024 12 20; 14(12):e080553.
    View in: PubMed
    Score: 0,192
  6. Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis. 2025 Apr; 25(4):457-470.
    View in: PubMed
    Score: 0,192
  7. Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children. Nat Commun. 2024 Sep 27; 15(1):8401.
    View in: PubMed
    Score: 0,189
  8. Demographic and pathogen characteristics of incident bacterial meningitis in infants in South Africa: A cohort study. PLoS One. 2024; 19(9):e0310528.
    View in: PubMed
    Score: 0,189
  9. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,188
  10. Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality. Vaccine. 2020 07 22; 38(34):5398-5401.
    View in: PubMed
    Score: 0,141
  11. Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005-2016. Vaccine. 2019 09 10; 37(38):5724-5730.
    View in: PubMed
    Score: 0,130
  12. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,104
  13. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,102
  14. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014 Nov 13; 371(20):1889-99.
    View in: PubMed
    Score: 0,095
  15. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine. 2013 Aug 28; 31(38):4200-8.
    View in: PubMed
    Score: 0,086
  16. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
    View in: PubMed
    Score: 0,082
  17. Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nat Commun. 2023 02 16; 14(1):888.
    View in: PubMed
    Score: 0,042
  18. Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study. Clin Infect Dis. 2023 02 08; 76(3):e710-e717.
    View in: PubMed
    Score: 0,042
  19. Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018. Emerg Infect Dis. 2022 01; 28(1):166-179.
    View in: PubMed
    Score: 0,039
  20. Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae. J Clin Microbiol. 2018 01; 56(1).
    View in: PubMed
    Score: 0,030
  21. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
    View in: PubMed
    Score: 0,027
  22. Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis. 2016 Feb; 22(2):261-70.
    View in: PubMed
    Score: 0,026
  23. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis. 2015 May 01; 60(9):1346-56.
    View in: PubMed
    Score: 0,024
  24. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,024
  25. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS. 2011 Feb 20; 25(4):453-62.
    View in: PubMed
    Score: 0,018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.